| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRC1 antisense RNA 1 | 0.931 | 0.154 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2010 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2007 | 2013 | |||||||||
|
T helper type 2 locus control region associated RNA | 0.751 | 0.385 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2010 | 2019 | |||||||||
|
papillary thyroid carcinoma susceptibility candidate 2 | 0.751 | 0.231 |
|
disease | 0.110 | None | 1.000 | 4 | 12 | 2009 | 2018 | |||||||||
|
MEF2C antisense RNA 1 | 0.861 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 4 | 5 | 2011 | 2014 | |||||||||
|
C2 antisense RNA 1 | 0.821 | 0.192 |
|
disease | 0.100 | None | 1.000 | 4 | 4 | 2010 | 2012 | |||||||||
|
long intergenic non-protein coding RNA 2341 | 0.751 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2012 | 2014 | |||||||||
|
KCNQ1 opposite strand/antisense transcript 1 | 0.534 | 0.731 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2010 | 2019 | |||||||||
|
CCDC26 long non-coding RNA | 0.647 | 0.615 |
|
disease | 0.100 | None | 1.000 | 4 | 64 | 2009 | 2017 | |||||||||
|
downregulated RNA in cancer, inhibitor of cell invasion and migration | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2008 | 2017 | |||||||||
|
ribosomal protein SA pseudogene 52 | 0.931 | 0.154 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2010 | 2018 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.200 | None | 0.958 | 4 | 42 | 2005 | 2019 | |||||||||
|
HNF1A antisense RNA 1 | 0.621 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 4 | 9 | 2012 | 2019 | |||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2010 | 2014 | |||||||||
|
BDNF antisense RNA | 0.638 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2009 | 2014 | |||||||||
|
BDNF antisense RNA | 0.638 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2009 | 2014 | |||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2008 | 2017 | |||||||||
|
HHIP antisense RNA 1 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 4 | 2 | 2008 | 2013 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.110 | None | 1.000 | 4 | 2 | 2007 | 2015 | |||||||||
|
ZBED3 antisense RNA 1 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2010 | 2018 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.430 | None | 1.000 | 3 | 97 | 2011 | 2018 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 0.978 | 3 | 23 | 2007 | 2019 | |||||||||
|
LIN28B antisense RNA 1 | 0.861 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 3 | 5 | 2009 | 2019 | |||||||||
|
RAB4B-EGLN2 readthrough (NMD candidate) | 0.641 | 0.654 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2012 | |||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 10 | 2007 | 2011 |